Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lammintausta

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|June 25, 2002
[What kind of new drugs will we get in the future and why?]R Lammintausta
International Journal of Clinical Pharmacology and Biopharmacy|December 1, 1978
The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancyR Lammintausta
Acta Veterinaria Scandinavica. Supplementum|January 1, 1986
Introduction to adrenoceptor pharmacologyR Lammintausta
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1980
Digoxin without effect on renin release in healthy subjectsR Lammintausta
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1981
Chlorpropamide bioavailability and pharmacokineticsR Huupponen, R Lammintausta
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1980
The renin-aldosterone system in low-dose chlorothiazide treatment of hypertensive subjectsR Lammintausta, K Lammintausta
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Human growth hormone and dopaminergic drugs, with special reference to deprenyl (selegiline): a summary of studies on volunteersM Koulu, R Lammintausta
Journal of Neural Transmission|January 1, 1981
Effects of L-deprenyl on human growth hormone secretionM Koulu, R Lammintausta
Duodecim; Laaketieteellinen Aikakauskirja|August 30, 2001
[Drug development--from receptor research to therapy]R Lammintausta, M Scheinin
International Journal of Clinical Pharmacology and Biopharmacy|July 1, 1979
Effect of spironolactone treatment on the renin-aldosterone system during pregnancyR Lammintausta, R Erkkola
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Duodecim; Laaketieteellinen Aikakauskirja|June 25, 2002
[What kind of new drugs will we get in the future and why?]R Lammintausta
International Journal of Clinical Pharmacology and Biopharmacy|December 1, 1978
The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancyR Lammintausta
Acta Veterinaria Scandinavica. Supplementum|January 1, 1986
Introduction to adrenoceptor pharmacologyR Lammintausta
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1980
Digoxin without effect on renin release in healthy subjectsR Lammintausta
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1981
Chlorpropamide bioavailability and pharmacokineticsR Huupponen, R Lammintausta
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1980
The renin-aldosterone system in low-dose chlorothiazide treatment of hypertensive subjectsR Lammintausta, K Lammintausta
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Human growth hormone and dopaminergic drugs, with special reference to deprenyl (selegiline): a summary of studies on volunteersM Koulu, R Lammintausta
Journal of Neural Transmission|January 1, 1981
Effects of L-deprenyl on human growth hormone secretionM Koulu, R Lammintausta
Duodecim; Laaketieteellinen Aikakauskirja|August 30, 2001
[Drug development--from receptor research to therapy]R Lammintausta, M Scheinin
International Journal of Clinical Pharmacology and Biopharmacy|July 1, 1979
Effect of spironolactone treatment on the renin-aldosterone system during pregnancyR Lammintausta, R Erkkola
Pageof 7